SCHEMBL7974007

SCHEMBL7974007

Oc1nc(-c2ccccn2)nc2ncn(Cc3cccc(F)c3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.41
FFAR1 O14842 5/20 0.39
GRM5 P41594 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
SCD O00767 1/20 0.37
EPHX2 P34913 1/20 0.37
PPARG P37231 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPK14 Q16539 1/20 0.36
LMNA P02545 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
HSD17B13 Q7Z5P4 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974053 0.88 MET (0.44) FFAR1KDM4E
SCHEMBL7985492 0.88 SMN1; SMN2 (0.42) NPC1RAB9AMEN1ALDH1A1KMT2A
SCHEMBL7992177 0.87 SMN1; SMN2 (0.42) FFAR1GRM5NPC1RAB9ACYP11B1
SCHEMBL7991788 0.87 CYP11B1 (0.46) GRM5CYP11B1CYP11B2ALDH1A1LMNA
SCHEMBL7988454 0.86 MAPK14 (0.41) KDM4CCYP11B1CYP11B2EPHX2PPARG
SCHEMBL7985791 0.86 CYP11B1 (0.40) KDM4CCYP11B1CYP11B2EPHX2PPARG
SCHEMBL7985456 0.85 GAA (0.48) FFAR1GRM5NPC1RAB9AMEN1
SCHEMBL7991669 0.84 HDAC1 (0.38) KDM4CCYP11B1CYP11B2EPHX2PPARG
SCHEMBL7985264 0.84 CYP11B1 (0.41) KDM4CCYP11B1CYP11B2EPHX2PPARG
SCHEMBL7988638 0.84 MET (0.42) CYP11B1CYP11B2EPHX2PPARGMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed